QNRX
Quoin Pharmaceuticals Ltd DRC
NASDAQ: QNRX · HEALTHCARE · BIOTECHNOLOGY
$6.21
-4.17% today
Updated 2026-05-01
Market cap
$9.83M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-14.80
Dividend yield
—
52W range
$5 – $24
Volume
0.1M
Quoin Pharmaceuticals Ltd DRC (QNRX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.98M | $-3.77M | $-4.98M | $-6.57M | $-5.71M | $-1.34M | $-5.72M | $-8.48M | $-7.86M | $-7.86M | $-13.54B |
| Capital expenditures | $85440.00 | $330645.00 | $74525.00 | $182462.00 | $34519.00 | $125000.00 | $625000.00 | $250000.00 | $3.00 | $0.00 | $4.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | $0.00 | $764007.00 | $1.09M | $1.26M | $1.15B |
| Free cash flow | $-2.07M | $-4.10M | $-5.05M | $-6.76M | $-5.74M | $-1.46M | $-6.35M | $-8.73M | $-7.86M | $-7.86M | $-13.54B |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | $65.27M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — |